XENE - Xenon Pharmaceuticals Inc.
IEX Last Trade
40.12
0 0%
Share volume: 129,398
Last Updated: Tue 24 Dec 2024 06:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.45%
PREVIOUS CLOSE
CHG
CHG%
$40.12
-2.13
0.06%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-10 | 2022-08-09 | 2022-11-08 | 2023-03-01 | 2023-05-09 | 2023-08-09 | |
| Cash flow financing | 7.876 M | 269.890 M | 699.000 K | 6.000 K | 0.000 | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -18.428 M | -16.868 M | -30.402 M | -32.732 M | -34.411 M | -33.221 M | |
| Net income | -19.371 M | -31.158 M | -37.150 M | -37.694 M | -41.727 M | -47.461 M | |
| Depreciation | 376.000 K | 375.000 K | 358.000 K | 515.000 K | 354.000 K | 602.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 2.923 M | 2.524 M | 2.482 M | 986.000 K | 2.222 M | 2.123 M | |
| Investing Cashflow | -48.888 M | 1.317 M | -234.097 M | -14.335 M | 46.622 M | 27.902 M | |
| Net Borrowings | -534.469 M | -784.428 M | -639.537 M | -588.877 M | -519.502 M | -530.987 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -212.000 K | -544.000 K | -386.000 K | -1.752 M | -2.206 M | -2.133 M | |
| Cash Change | 537.940 M | 788.238 M | 638.185 M | 592.087 M | 527.043 M | 539.600 M |